Chih-Hsin Yang, MD
National Taiwan University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chih-Hsin Yang, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:35 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03819465 · A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLCAstraZeneca · active not recruiting · Metastatic Non-Small Cell Lung Cancer (NSCLC) · principal investigator
- Ph1/Ph2NCT02025114 · Selumetinib in Combination With Gefitinib in NSCLC PatientsNational Taiwan University Hospital · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- Ph2NCT01922583 · AUY922 in Patient With Stage IV NSCLCNational Taiwan University Hospital · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- N/ANCT01637597 · Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase TranslocationNational Taiwan University Hospital · unknown · Non-small Cell Lung Cancer(NSCLC) · principal investigator
- Ph1NCT01147211 · Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)National Taiwan University Hospital · unknown · Non Small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.